Drugs / GSK625433
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00439959 | Oct 2006 → Mar 2007 | chronic hepatitis C virus infection | GlaxoSmithKline | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK625433 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00439959 ↗ |
| Modality | Small molecule | — CHEMBL2024212 ↗ |